Celularity Inc.: DCF model
A discounted-cash-flow model filled in from Celularity Inc.'s filings as reported. Change any assumption; the values follow at once.
A tool for your own analysis, not investment advice. It does arithmetic on the figures the company filed and on assumptions you choose; it does not forecast, and the result is only as good as those assumptions. Every formula is on the methodology page.
Market price USD 0.85 on Oct 30, 2026: Closing price the SEC publishes with its fails-to-deliver data (CELU).
Assumptions: Base case
Change any figure; the values follow at once.
Revenue and margins
From the filings10-K filed Apr 30, 2026
The years between change on a straight line.
From the filingsThe first year starts at Revenue growth a year from FY2022 to FY2025 (3 years): 13.88% a year; the years after are your assumption.
The years between change on a straight line.
Your figureAverage operating margin, FY2023–FY2025: -382.03%; the years ahead are your assumption.
Tax and reinvestment
Your assumptionThe effective rate cannot be worked out (losses or no tax line): 25% to start with.
From the filingsAverage share of revenue, FY2023–FY2025
From the filingsAverage share of revenue, FY2023–FY2024
Your figureAverage operating working capital (current assets less cash and short-term investments, less current liabilities other than debt) as a share of revenue, FY2023–FY2025
Discount rate
Your assumption1.0 to start with
Your assumption5% to start with
Your assumptionNot on file: the risk-free rate plus 1.5 points.
From the filingsDebt over debt plus market value on Oct 30, 2026
After the last year
Your assumption2.5% to start with.
From value to shares (every case)
Balance sheet of Q2FY2026, Jun 30, 2026 · 10-Q filed Oct 20, 2026
From the filings
From the filings
From the filings
From the filings
Your assumption
From the filingsdiluted, weighted average, Q2FY2026 · 10-Q filed Oct 20, 2026
The three cases
Base case: value per share
Discount rate 10.15%; long-run growth 2.50%. Values as at the end of FY2025.
| Present value of the 5 projected years | −USD 94 M |
|---|---|
| Present value after the last year | −USD 238 M |
| Enterprise value (the whole business) | −USD 332 M |
| Less debt | USD 0 |
| Plus cash and short-term investments | USD 586,000 |
| Equity value (the shareholders') | −USD 332 M |
| Divided by shares (millions) | 29.3 |
| Value per share | USD -11.31 |
Value per share
USD -11.31
Below zero: with these figures the debt is worth more than the business.
Price USD 0.85 on Oct 30, 2026
Base case: year by year
Millions of USD. The FY2025 column is as reported; the years after are projected. Tax, capital spending and working capital are signed as they add to (+) or take from (−) free cash flow.
| USD millions | FY2025reported | FY2026projected | FY2027projected | FY2028projected | FY2029projected | FY2030projected |
|---|---|---|---|---|---|---|
| Revenue | 27 | 30 | 34 | 36 | 38 | 39 |
| Growth | -51.0% | 13.9% | 11.0% | 8.2% | 5.3% | 2.5% |
| Operating income (EBIT) | −61 | −30 | −34 | −36 | −38 | −39 |
| Operating margin | -230.9% | -100.0% | -100.0% | -100.0% | -100.0% | -100.0% |
| Tax on operating income | −0 | −0 | −0 | −0 | −0 | |
| Depreciation and amortisation | 7.3 | 8.4 | 9.3 | 10 | 11 | 11 |
| Capital spending | — | −0.7 | −0.8 | −0.9 | −0.9 | −1 |
| Change in working capital | 1.8 | 1.7 | 1.4 | 1 | 0.5 | |
| Free cash flow to the firm | −13 | −21 | −23 | −26 | −28 | −29 |
| Discount factor | 0.9079 | 0.8242 | 0.7482 | 0.6793 | 0.6167 | |
| Present value | −19 | −19 | −19 | −19 | −18 |
Base case: sensitivity
How the value per share moves when one pair of figures changes and the rest stay as they are.
Discount rate and long-run growth
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Discount rate ↓ · Long-run growth → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 8.15% | -13.51 | -14.38 | -15.42 | -16.65 | -18.15 |
| 9.15% | -11.69 | -12.32 | -13.05 | -13.9 | -14.9 |
| 10.15% | -10.3 | -10.77 | -11.31 | -11.92 | -12.62 |
| 11.15% | -9.19 | -9.56 | -9.97 | -10.42 | -10.94 |
| 12.15% | -8.3 | -8.59 | -8.9 | -9.26 | -9.65 |
Revenue growth and operating margin
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Growth, every year ↓ · Margin, every year → | −4 pt | −2 pt | ±0 pt | +2 pt | +4 pt |
|---|---|---|---|---|---|
| −4 pt | -10.36 | -10.1 | -9.83 | -9.57 | -9.31 |
| −2 pt | -11.12 | -10.84 | -10.55 | -10.26 | -9.98 |
| ±0 pt | -11.93 | -11.62 | -11.31 | -11 | -10.69 |
| +2 pt | -12.79 | -12.45 | -12.11 | -11.77 | -11.44 |
| +4 pt | -13.7 | -13.33 | -12.96 | -12.6 | -12.23 |
Where the figures come from
The statements as reported, in millions of USD; hover a figure for its filing.
| USD millions | FY2025to Dec 31, 2025 | FY2024to Dec 31, 2024 | FY2023to Dec 31, 2023 | FY2022to Dec 31, 2022 | FY2021to Dec 31, 2021 | FY2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 27 | 54 | 23 | 18 | 21 | 14 |
| Growth | -51.0% | 138.1% | 26.7% | -15.7% | 49.4% | — |
| Operating income | −61 | −38 | −192 | −26 | −109 | −152 |
| Operating margin | -230.9% | -70.7% | -844.4% | -142.4% | -511.2% | -1064.0% |
| Effective tax rate | — | — | — | 0.1% | — | — |
| D&A, % of revenue | 27.5% | 14.6% | 40.9% | 52.5% | 41.3% | 57.2% |
| Capital spending, % of revenue | — | 0.3% | 4.6% | 29.1% | 29.1% | 194.9% |
| Working capital, % of revenue | -281.0% | -62.4% | -37.3% | -236.7% | -20.5% | -61.8% |
| Free cash flow to the firm | −13 | −5.2 | −218 | 17 | −111 | — |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
- No debt is tagged on the balance sheet of Q2FY2026: debt starts at zero.
- From the filings: revenue, margins, tax rate, depreciation, capital spending and working capital (fiscal years above), debt, cash, leases and minority interests (balance sheet of Q2FY2026), and the share count (Q2FY2026).
- Market data: US Treasury daily par yield curve, 10-year (Nov 13, 2026); Market price USD 0.85 on Oct 30, 2026: Closing price the SEC publishes with its fails-to-deliver data (CELU).
- Your assumptions: the growth path and margins ahead, beta, the equity risk premium, long-run growth or the exit multiple, and the weights of the cases. How each figure is worked out: methodology.